January 24, 2017
Breathometer, the Mark Cuban-backed digital health startup that makes a smartphone-connected oral health sensor, has settled a suit with the Federal Trade Commission over its first product, a smartphone-connected breathalyzer. According to the terms of the settlement, Breathometer will have to offer a full refund to customers who bought the device.
The FTC says that it discovered serious accuracy...
December 13, 2016
Newport Beach, California-based AuraLabs has agreed to settle charges from the Federal Trade Commission over claims that their Instant Blood Pressure app was accurate and could even replace traditional blood pressure cuffs. Additionally, AuraLabs Founder and CEO Ryan Archdeacon was also accused of leaving five-star positive reviews of Instant Blood Pressure in app stores without disclosing his...
September 12, 2016
Teladoc's antitrust lawsuit against the Texas Medical Board (TMB) is still a long way from over, but an amicus curie brief filed this morning in the Fifth Circuit Court shows that the telemedicine company has friends in high places: namely, the US Federal Trade Commission.
A quick refresher: Teladoc sued the TMB in state court way back in April 2015, alleging that because the board was made up of...
August 17, 2016
On Tuesday, the U.S. Federal Trade Commission approved a final order with EHR vendor Practice Fusion that will consent to a 20-year privacy practice order, stemming from its highly-publicized privacy scandal.
The settlement was first announced in June, and after a 30-day comment period, the final order was unanimously approved, 3-0.
Practice Fusion was charged with soliciting reviews from...
April 6, 2016
The Federal Trade Commission (FTC) has released a new interactive tool on its website, with help from the Office of National Coordinator for Health Information Technology (ONC), Office for Civil Rights (OCR) and the Food and Drug Administration (FDA), to help health app developers to determine whether certain regulations apply to their app.
“Mobile app developers need clear information about the...
March 1, 2016
About five months after the Federal Trade Commission (FTC) first charged the marketers of a vision improvement app, called UltimEyes, with deceptively claiming their program was scientifically proven to improve the user's eye sight, the FTC has approved a final consent order that requires the company to stop making these claims.
Carrot Neurotechnology, the company behind the UltimEyes, charges $9...
January 14, 2016
The FTC’s PrivacyCon, an all day event that included presentations and discussions from a number of privacy researchers, one presentation focused on the data privacy risks associated with direct to consumer genomic data services. Many of these risks apply to any consumer health data service.
Researchers Jan Charbonneau and Andelka Phillips, of the University of Tasmania and the University of...
September 21, 2015
The Federal Trade Commission (FTC) has charged the marketers of a vision improvement app, called UltimEyes, with deceptively claiming they their program was scientifically proven to improve the user's eye sight. The company behind the app, Carrot Neurotechnology, and its co-owners Adam Goldberg and Aaron Seitz have agreed to pay $150,000 and to stop citing the claims. Notably, the $5.99 app is...
April 13, 2015
A brain training game fined by the FTC earlier this year.
Developers of mobile health apps need to be mindful of regulation from a number of different quarters. Among others, developers need to be aware of the FDA, OCR (HIPAA), and the FTC, which is increasingly regulating areas that would seem to be the purview of one of the other two groups.
At a HIMSS session on mobile and digital health...
March 30, 2015
A recent Supreme Court decision could have a profound impact on the ability of state medical boards to prevent telemedicine companies from offering their services, according to some experts familiar with the case.
North Carolina Board of Dental (NCBD) Examiners vs Federal Trade Commission was decided by a 6-3 vote last month. The case ruled that medical boards comprised of private professionals (...